Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS-CoV-2 Infection in an Immunocompromised Patient.
Brandolini M, Zannoli S, Gatti G, Arfilli V, Cricca M, Dirani G, Denicolò A, Semprini S, Grumiro L, Imola M, Larne D, Marino MM, Manera M, Mancini A, Taddei F, Zagarrigo M, Biagetti C, Sambri V. Brandolini M, et al. Among authors: imola m. Viruses. 2023 Jan 19;15(2):291. doi: 10.3390/v15020291. Viruses. 2023. PMID: 36851504 Free PMC article.
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).
Russo D, Polverelli N, Malagola M, Farina M, Leoni A, Bernardi S, Mammoliti S, Sacchi N, Martino M, Ciceri F; GITMO Centers. Russo D, et al. Bone Marrow Transplant. 2021 Sep;56(9):2272-2275. doi: 10.1038/s41409-021-01287-w. Epub 2021 Apr 19. Bone Marrow Transplant. 2021. PMID: 33875810 Free PMC article.
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study.
Zannetti BA, Saraceni F, Cellini C, Fabbri E, Monaco F, Guarini A, Laszlo D, Martino M, Olivieri A, Imola M, Tosi P, Chiarucci M, Zuffa E, Lanza F. Zannetti BA, et al. Among authors: imola m. Transplant Cell Ther. 2021 Mar;27(3):244.e1-244.e8. doi: 10.1016/j.jtct.2020.12.009. Epub 2021 Jan 28. Transplant Cell Ther. 2021. PMID: 33781522 Free article.
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey.
Girmenia C, Bertaina A, Piciocchi A, Perruccio K, Algarotti A, Busca A, Cattaneo C, Raiola AM, Guidi S, Iori AP, Candoni A, Irrera G, Milone G, Marcacci G, Scimè R, Musso M, Cudillo L, Sica S, Castagna L, Corradini P, Marchesi F, Pastore D, Alessandrino EP, Annaloro C, Ciceri F, Santarone S, Nassi L, Farina C, Viscoli C, Rossolini GM, Bonifazi F, Rambaldi A; Gruppo Italiano Trapianto di Midollo Osseo (GITMO) and Associazione Microbiologi Clinici Italiani (AMCLI). Girmenia C, et al. Clin Infect Dis. 2017 Nov 13;65(11):1884-1896. doi: 10.1093/cid/cix690. Clin Infect Dis. 2017. PMID: 29020286 Free article. Clinical Trial.
Temporomandibular joint reconstruction.
Imola MJ, Liddell A. Imola MJ, et al. Curr Opin Otolaryngol Head Neck Surg. 2016 Aug;24(4):336-42. doi: 10.1097/MOO.0000000000000282. Curr Opin Otolaryngol Head Neck Surg. 2016. PMID: 27348350 Review.
Early application of percutaneous vertebroplasty reduces pain without affecting peripheral blood stem cell (PBSC) collection and transplant in newly diagnosed multiple myeloma (MM) patients.
Tosi P, Sintini M, Molinari AL, Imola M, Ciotta G, Tomassetti S, Mianulli AM, Ratta M, Mangianti S, Merli A, Polli V. Tosi P, et al. Among authors: imola m. Eur J Cancer Care (Engl). 2014 Nov;23(6):773-8. doi: 10.1111/ecc.12158. Epub 2013 Dec 2. Eur J Cancer Care (Engl). 2014. PMID: 24289239
Lenalidomide in combination with dexamethasone in elderly patients with advanced, relapsed or refractory multiple myeloma and renal failure.
Tosi P, Gamberi B, Castagnari B, Molinari AL, Savini P, Ceccolini M, Tani M, Merli A, Imola M, Mianulli AM, Cellini C, Tomassetti S, Merli F, Fattori P, Zaccaria A. Tosi P, et al. Among authors: imola m. Mediterr J Hematol Infect Dis. 2013 Jun 3;5(1):e2013037. doi: 10.4084/MJHID.2013.037. Print 2013. Mediterr J Hematol Infect Dis. 2013. PMID: 23795275 Free PMC article.
Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma.
Lanza F, Lemoli RM, Olivieri A, Laszlo D, Martino M, Specchia G, Pavone V, Imola M, Pasini A, Milone G, Scortechini I, Todisco E, Guggiari E, Cascavilla N, Martinelli G, Rambaldi A, Bosi A. Lanza F, et al. Among authors: imola m. Transfusion. 2014 Feb;54(2):331-9. doi: 10.1111/trf.12265. Epub 2013 Jun 19. Transfusion. 2014. PMID: 23781769
27 results